Kopaq

Iohexol, the active ingredient in Kopaq, is a iodinated contrast media presented as an unknown/unknown for intraarterial, intrathecal, intravenous use. It provides radiodensity for imaging procedures in patients undergoing angiography, CT imaging, myelography, urography and venography.

GNH USA supplies Kopaq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kopaq, an iodinated contrast agent, is used in radiographic imaging procedures to enhance visualization of vascular and organ structures.

- Angiography: improves visualization of blood vessels during catheter‑based studies. - Computed tomography (CT) imaging: enhances contrast between tissues for detailed cross‑sectional images. - Myelography: delineates the spinal canal and nerve roots after intrathecal injection. - Urography: highlights the urinary tract, facilitating detection of stones or obstruction. - Venography: clarifies venous structures for diagnostic assessment.

Adverse reactions may occur following administration of iodinated contrast media.

Common Side Effects: - Warm or flushing sensation at the injection site. - Nausea or vomiting. - Mild headache. - Transient hypotension. - Metallic taste in the mouth. - Mild itching or urticaria.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Acute renal impairment or contrast‑induced nephropathy. - Seizures or convulsions. - Cardiac arrhythmias or severe hypotension. - Pulmonary edema. - Life‑threatening cardiovascular collapse.

When using Kopaq, careful patient assessment and monitoring are essential.

- Assess renal function: evaluate serum creatinine and eGFR before administration. - Screen for iodine allergy: obtain a detailed history of prior contrast reactions. - Use the lowest effective volume: adjust dose based on patient size and imaging requirement. - Monitor vital signs: observe blood pressure and heart rate during and after injection. - Avoid in uncontrolled hyperthyroidism: consider alternative imaging strategies. - Store at room temperature: keep in original container, protect from light and moisture.

Iohexol may interact with other medications that affect renal function or iodine metabolism.

Major Interactions (Avoid): - Concurrent iodinated contrast agents: cumulative iodine load can increase toxicity. - Metformin in patients with renal impairment: risk of lactic acidosis. - Thyroid hormone therapy: may exacerbate hyperthyroid states.

Moderate Interactions (Monitor Closely): - NSAIDs: can worsen renal function when combined with contrast. - ACE inhibitors or ARBs: may increase risk of contrast‑induced nephropathy. - Diuretics: may affect fluid balance and renal clearance.